189 related articles for article (PubMed ID: 35816372)
1. Ophthalmic histiocytic lesions (diseases of the L group): A multicenter clinicopathological study of 18 cases and review of literature.
Alzahem T; Alkatan HM; Maktabi AM; Alsulaiman N; Cruz AAV
Eur J Ophthalmol; 2023 Jan; 33(1):556-566. PubMed ID: 35816372
[TBL] [Abstract][Full Text] [Related]
2. Ophthalmologic Involvement in Adults with Histiocytic Disorders: Clinical Presentation and Treatment Outcomes.
Banks SA; Bhatti MT; Go RS; Abeykoon JP; Acosta-Medina AA; Hazim AZ; Goyal G; Young JR; Koster MJ; Vassallo R; Ryu JH; Davidge-Pitts CJ; Ravindran A; Sartori Valinotti JC; Bennani NN; Shah MV; Rech KL; Garrity JA; Tobin WO;
Ophthalmology; 2023 Jan; 130(1):77-86. PubMed ID: 35932838
[TBL] [Abstract][Full Text] [Related]
3. Dramatic efficacy of dabrafenib in Erdheim-Chester disease (ECD): a pediatric patient with multiple large intracranial ECD lesions hidden by refractory Langerhans cell histiocytosis.
Hao X; Feng R; Bi Y; Liu Y; Li C; Lu T; Tian Y
J Neurosurg Pediatr; 2018 Sep; 23(1):48-53. PubMed ID: 30265230
[TBL] [Abstract][Full Text] [Related]
4. Presence of Erdheim-Chester disease and Langerhans cell histiocytosis in the same patient: a report of 2 cases.
Pineles SL; Liu GT; Acebes X; Arruga J; Nasta S; Glaser R; Pramick M; Fogt F; Roux PL; Gausas RE
J Neuroophthalmol; 2011 Sep; 31(3):217-23. PubMed ID: 21326112
[TBL] [Abstract][Full Text] [Related]
5. Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation.
Hervier B; Haroche J; Arnaud L; Charlotte F; Donadieu J; Néel A; Lifermann F; Villabona C; Graffin B; Hermine O; Rigolet A; Roubille C; Hachulla E; Carmoi T; Bézier M; Meignin V; Conrad M; Marie L; Kostrzewa E; Michot JM; Barete S; Taly V; Cury K; Emile JF; Amoura Z;
Blood; 2014 Aug; 124(7):1119-26. PubMed ID: 24894769
[TBL] [Abstract][Full Text] [Related]
6. Comparison of neuroimaging features of histiocytic neoplasms with central nervous system involvement: a retrospective study of 121 adult patients.
Fan X; Liu T; Zhang Z; Sun J; Niu N; Mao C; Wang F; Li J; Zhou D; Cao X; Jin Z; Feng F
Eur Radiol; 2023 Nov; 33(11):8031-8042. PubMed ID: 37191919
[TBL] [Abstract][Full Text] [Related]
7. Ophthalmic histiocytic lesions: a baseline demographic and clinicopathological study of 28 cases from two eye centers.
Alkatan HM; Alzahem TA; Maktabi AMY
Int Ophthalmol; 2022 Apr; 42(4):1221-1232. PubMed ID: 34727265
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary manifestations of Erdheim-Chester disease: clinical characteristics, outcomes and comparison with Langerhans cell histiocytosis.
Wang JN; Wang FD; Sun J; Liang ZY; Li J; Zhou DB; Tian X; Cao XX
Br J Haematol; 2021 Sep; 194(6):1024-1033. PubMed ID: 34423426
[TBL] [Abstract][Full Text] [Related]
9. Mixed Langerhans Cell Histiocytosis and Erdheim-Chester Disease in a Girl: A Rare and Puzzling Diagnosis.
Ocak S; Bayramoglu Z; Tugcu D; Karaman S; Unuvar A; Karakas Z
J Pediatr Hematol Oncol; 2021 Apr; 43(3):e375-e379. PubMed ID: 32097280
[TBL] [Abstract][Full Text] [Related]
10. The clinical spectrum and prognostic factors of Erdheim-Chester disease and mixed Langerhans cell histiocytosis and Erdheim-Chester disease.
Dai JW; Lin H; Chang L; Li J; Zhou DB; Cao XX
Ann Hematol; 2023 Dec; 102(12):3335-3343. PubMed ID: 37922006
[TBL] [Abstract][Full Text] [Related]
11. Coexistence of intracranial Langerhans cell histiocytosis and Erdheim-Chester disease in a pediatric patient: a case report.
Kim S; Lee M; Shin HJ; Lee J; Suh YL
Childs Nerv Syst; 2016 May; 32(5):893-6. PubMed ID: 26466952
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathological and molecular features of Erdheim-Chester disease accompanied with Langerhans cell histiocytosis].
Huang HJ; Zhong DR
Zhonghua Bing Li Xue Za Zhi; 2019 Mar; 48(3):220-224. PubMed ID: 30831649
[No Abstract] [Full Text] [Related]
13. Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study.
Diamond EL; Subbiah V; Lockhart AC; Blay JY; Puzanov I; Chau I; Raje NS; Wolf J; Erinjeri JP; Torrisi J; Lacouture M; Elez E; Martínez-Valle F; Durham B; Arcila ME; Ulaner G; Abdel-Wahab O; Pitcher B; Makrutzki M; Riehl T; Baselga J; Hyman DM
JAMA Oncol; 2018 Mar; 4(3):384-388. PubMed ID: 29188284
[TBL] [Abstract][Full Text] [Related]
14. Histopathological and Clinical Findings in Cutaneous Manifestation of Erdheim-Chester Disease and Langerhans Cell Histiocytosis Overlap Syndrome Associated With the BRAFV600E Mutation.
Liersch J; Carlson JA; Schaller J
Am J Dermatopathol; 2017 Jul; 39(7):493-503. PubMed ID: 27898473
[TBL] [Abstract][Full Text] [Related]
15. An unusual case of Erdheim-Chester disease with features of Langerhans cell histiocytosis.
Furmanczyk PS; Bruckner JD; Gillespy T; Rubin BP
Skeletal Radiol; 2007 Sep; 36(9):885-9. PubMed ID: 17492445
[TBL] [Abstract][Full Text] [Related]
16. Highlights of the Management of Adult Histiocytic Disorders: Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Rosai-Dorfman Disease, and Hemophagocytic Lymphohistiocytosis.
Salama HA; Jazieh AR; Alhejazi AY; Absi A; Alshieban S; Alzahrani M; Alaskar A; Gmati G; Damlaj M; Abuelgasim KA; Alghamdi A; Alahmari B; Almugairi A; Alzahrani H; Bazarbachi A; Musa MOH; Goyal G
Clin Lymphoma Myeloma Leuk; 2021 Jan; 21(1):e66-e75. PubMed ID: 32943371
[TBL] [Abstract][Full Text] [Related]
17. Erdheim-Chester disease: expanding the spectrum of cutaneous manifestations.
Kobic A; Shah KK; Schmitt AR; Goyal G; Go RS; Guo R; Rech KL; Sartori-Valinotti JC;
Br J Dermatol; 2020 Feb; 182(2):405-409. PubMed ID: 31120137
[TBL] [Abstract][Full Text] [Related]
18. Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1.
Gatalica Z; Bilalovic N; Palazzo JP; Bender RP; Swensen J; Millis SZ; Vranic S; Von Hoff D; Arceci RJ
Oncotarget; 2015 Aug; 6(23):19819-25. PubMed ID: 26110571
[TBL] [Abstract][Full Text] [Related]
19. Hand-Schüller-Christian disease and Erdheim-Chester disease: coexistence and discrepancy.
Yin J; Zhang F; Zhang H; Shen L; Li Q; Hu S; Tian Q; Bao Y; Jia W
Oncologist; 2013; 18(1):19-24. PubMed ID: 23299772
[TBL] [Abstract][Full Text] [Related]
20. [Associated Langerhans cell histiocytosis and Erdheim-Chester disease].
Marchal A; Cuny JF; Montagne K; Haroche J; Barbaud A; Schmutz JL
Ann Dermatol Venereol; 2011 Nov; 138(11):743-7. PubMed ID: 22078035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
